Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents-Reference-Cited by-同舟云学术

Are Antidepressant Drugs That Combine Serotonergic and Noradrenergic Mechanisms of Action More Effective Than the Selective Serotonin Reuptake Inhibitors in Treating Major Depressive Disorder? A Meta-analysis of Studies of Newer Agents

Published:2007-12 Issue:11 Volume:62 Page:1217-1227
ISSN:0006-3223
Container-title:Biological Psychiatry
language:en
Short-container-title:Biological Psychiatry

Author:

Papakostas George I.,Thase Michael E.,Fava Maurizio,Nelson J. Craig,Shelton Richard C.

Publisher

Elsevier BV

Subject

Biological Psychiatry

Reference141 articles.

1. Monoamine-based pharmacotherapy;Papakostas,2005

2. Citalopram: Clinical effect profile in comparison with clomipramine. A controlled multicenter study;Psychopharmacology (Berl),1986

3. Paroxetine: A selective serotonin reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study;J Affect Disord,1990

4. Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability;Anderson;J Affect Disord,2000

5. Remission rates during treatment with venlafaxine or selective serotonin reuptake inhibitors;Thase;Br J Psychiatry,2001

Cited by 259 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assessing the efficacy and safety of combined buspirone and venlafaxine treatment in late-life depression accompanied by cognitive impairment: A randomized controlled trial;General Hospital Psychiatry;2024-11

2. Synthesis and biological evaluation of multimodal monoaminergic arylpiperazine derivatives with potential antidepressant profile;European Journal of Medicinal Chemistry;2024-09

3. Design, Synthesis and Biological Evaluation of Novel Ketamine Derivatives as NMDAR Antagonists;Molecules;2024-05-23

4. Decision Points in Iterative Pharmacotherapy;Clinical Reasoning and Decision-Making in Psychiatry;2024-03-31

5. Hypothesis-Testing and Crafting Patient-Specific Decision Trees;Clinical Reasoning and Decision-Making in Psychiatry;2024-03-31